Predictors of Gleason score upgrading in a large African-American population

International Urology and Nephrology

Volumn 45, Issue 5, 2013, Pages 1257-1262

  Vora, Anup ^a   Large, Tim ^a   Aronica, Jenny ^a   Haynes, Sherod ^a   Harbin, Andrew ^a   Marchalik, Daniel ^a   Nissim, Hanaa ^a   Lynch, John ^a   Bandi, Gaurav ^a   McGeagh, Kevin ^a   Kowalczyk, Keith ^a   Ghasemian, Reza ^a   Venkatesan, Krishnan ^a   Verghese, Mohan ^a   Hwang, Jonathan ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Active surveillance; African American; Gleason score upgrading; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER OF THE PROSTATE RISK ASSESSMENT SCORE; CANCER SIZE; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE; RACE DIFFERENCE; SCORING SYSTEM; TRANSRECTAL ULTRASONOGRAPHY; UNITED STATES; URBAN POPULATION;

ADENOCARCINOMA; AFRICAN AMERICANS; AGED; BODY MASS INDEX; HUMANS; IMAGE-GUIDED BIOPSY; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 84887473487     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0495-y     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E et al (2006) Cancer statistics. CA Cancer J Clin 56:106-130
2. Turley RS, Terris MK, Kane CJ, Aronson WJ, Presti JC Jr, Amling CL, Freedland SJ (2008) The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the shared equal access regional cancer hospital database. BJU Int 102(9):1074-1079
3. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280(11):969-974
4. Fu Q, Moul JW, Bañez LL, Sun L, Mouraviev V, Xie D, Polascik TJ (2008) Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer. Med Oncol 29(5):3339-3344
5. Oh JJ, Hong SK, Lee JK, Lee BK, Lee S, Kwon OS, Byun SS, Lee SE (2012) Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy. BJU Int 110(11 Pt B):E494-E499
6. Gleason DF, Mellinger GT (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111(1):58-64
7. Cohen MS, Hanley RS, Kurteva T, Ruthazer R, Silverman ML, Sorcini A, Hamawy K, Roth RA, Tuerk I, Libertino JA (2008) Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey clinic medical center experience and an international meta-analysis. Eur Urol 54(2):371-381
8. Cookson MS, Fleshner NE, Soloway SM, Fair WR (1997) Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 157(2):559-562
9. Cecchi M, Minervini R, Sepich CA, Ippolito C, Pagni GL, Summonti D, Di Benedetto A, Fiorentini L (1998) Correlation between Gleason score of needle biopsy and radical prostatectomy tissue. Int Urol Nephrol 30(5):575-580
10. Fernandes ET, Sundaram CP, Long R, Soltani M, Ercole CJ (1997) Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer? Br J Urol 79(4):615-617
11. Davies JD, Aghazadeh MA, Phillips S, Salem S, Chang SS, Clark PE, Cookson MS, Davis R, Herrell SD, Penson DF, Smith JA Jr, Barocas DA (2011) Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer. J Urol 186(6):2221-2227
12. Turley RS, Hamilton RJ, Terris MK, Kane CJ, Aronson WJ, Presti JC Jr, Amling CL, Freedland SJ (2008) Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. J Urol 179(2):523-527
13. Thomas C, Pfirrmann K, Pieles F, Bogumil A, Gillitzer R, Wiesner C, Thüroff JW, Melchior SW (2012) Predictors for clinically relevant Gleason score upgrade in patients undergoing radical prostatectomy. BJU Int 109(2):214-219
14. Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL (2012) The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume. BJU Int 110(1):36-42
15. Tilki D, Schlenker B, John M, Buchner A, Stanislaus P, Gratzke C, Karl A, Tan GY, Ergün S, Tewari AK, Stief CG, Seitz M, Reich O (2011) Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series. Urol Oncol 29(5):508-514
16. Epstein JI, Feng Z, Trock BJ, Pierorazio PM (2012) Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol 61(5):1019-1024
17. Gershman B, Dahl DM, Olumi AF, Young RH, Scott McDougal W, Wu CL (2011) Smaller prostate gland size and older age predict Gleason score upgrading. Urol Oncol (epub)
18. Altekruse SF, Kosary CL, Krapcho M et al. (2008) SEER cancer statistics review, 1975-2007, National Cancer Institute. Bethesda, MD. http://seer.cancer. gov/csr/1975-2007/
19. Powell IJ (2011) The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis. Arch Esp Urol 64(8):711-719
20. Powell IJ, Bock CH, Ruterbusch JJ, Sakr W (2010) Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol 183(5):1792-1796
21. Bigler SA, Pound CR, Zhou X (2011) A retrospective study on pathologic features and racial disparities in prostate cancer. Prostate Cancer 239460:101-108
22. Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR (2005) The University of California, San Francisco cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 173(6):1938-1942
23. Meurs P, Galvin R, Fanning DM, Fahey T (2012) Prognostic value of the CAPRA clinical prediction rule: a systematic review and meta-analysis. BJU Int 111(3):427-436